RxDoctor Payments Data

Lori Drumm

Family Medicine · Deer Lodge, MTNPI 1750393757

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $682 and has fallen 90.5% since, to $65 in 2024. Among family medicine clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,774in general payments, 2019–2025

Across 107 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$398
  • Amgen$321
  • Novo Nordisk$210
  • Teva Pharmaceuticals USA, Inc.$149
  • AstraZeneca$131
  • Biohaven Pharmaceutical Holding Company Ltd.$79
  • plus $485 from 16 others

What the payments were for

  • Food & beverage$1,774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,774 in reported general payments places this provider in the 90th percentile of 426 family medicine providers in Montana.

See all family medicine providers in Montana

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$70,092
OzempicSemaglutide50$60,745
EliquisApixaban66$43,233
MounjaroTirzepatide43$42,120
TrulicityDulaglutide36$37,784
FarxigaDapagliflozin Propanediol48$34,184
XareltoRivaroxaban42$33,209
JardianceEmpagliflozin34$31,243
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$16,545
JanuviaSitagliptin Phosphate16$16,237
Breo ElliptaFluticasone/Vilanterol24$10,806
InvokanaCanagliflozin21$8,254
EntrestoSacubitril/Valsartan16$7,611
DapagliflozinDapagliflozin Propanediol13$6,663
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$4,373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$60$81,45492 claims
GSKTrelegy Ellipta, Breo Ellipta$62$80,899122 claims
Novo NordiskOzempic$210$60,74550 claims
AstraZenecaFarxiga, Breztri Aerosphere$131$50,72972 claims
PfizerEliquis$14$43,23366 claims
Johnson & JohnsonXarelto, Invokana$73$41,46363 claims
Boehringer IngelheimJardiance$31$31,24334 claims
MerckJanuvia$14$16,23716 claims
NovartisEntresto$59$7,61116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 426 family medicine providers in Montana.

Other family medicine in Deer Lodge

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →